Macleods Pharms Ltd Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MACLEODS PHARMS LTD
MACLEODS PHARMS LTD has one hundred and fifty-nine approved drugs.
There are thirteen tentative approvals on MACLEODS PHARMS LTD drugs.
Summary for Macleods Pharms Ltd
| US Patents: | 0 |
| Tradenames: | 131 |
| Ingredients: | 130 |
| NDAs: | 159 |
Drugs and US Patents for Macleods Pharms Ltd
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Macleods Pharms Ltd | ZOLMITRIPTAN | zolmitriptan | TABLET, ORALLY DISINTEGRATING;ORAL | 204336-002 | Oct 22, 2015 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Macleods Pharms Ltd | TADALAFIL | tadalafil | TABLET;ORAL | 207244-001 | Oct 7, 2019 | AB1 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Macleods Pharms Ltd | CELECOXIB | celecoxib | CAPSULE;ORAL | 204590-004 | Mar 16, 2016 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for MACLEODS PHARMS LTD drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | for Injection | 200 mcg/vial | ➤ Subscribe | 2015-05-01 |
| ➤ Subscribe | for Injection | 100 mcg/vial and 500 mcg/vial | ➤ Subscribe | 2015-04-14 |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
